Showing results (181-190 of 2,810) with videos related to
Sort By:
Pageof 281
Expert Opinion on Drug Safety|May 3, 2014
Aspirin and age-related macular degeneration: positives versus negativesJerzy Z NowakExpert Opinion on Drug Safety|December 8, 2016
Safety and tolerability of glucagon-like peptide-1 receptor agonists: unresolved and emerging issuesDenis RaccahExpert Opinion on Drug Safety|November 11, 2021
Search of official nationwide database in Japan for adverse events associated with disease-modifying antirheumatic drug therapies: focus on therapies in combination with methotrexateShigeko InokumaExpert Opinion on Drug Safety|November 5, 2021
Neuropsychiatric adverse drug reactions associated with low dose methotrexate in rheumatoid arthritis patientsJette A Van Lint, Tom Bakker, Peter M Ten Klooster, et al.Expert Opinion on Drug Safety|December 17, 2021
Proton pump inhibitors and increased reporting odds of renal neoplasms: FAERS-based adverse event data mining and analysisWeijuan Song, Lei Shi, Yanhong Wang, et al.Expert Opinion on Drug Safety|September 4, 2019
The role of therapeutic drug monitoring in the management of safety of anticancer agents: a focus on 3 cytotoxicsDominique Levêque, Guillaume BeckerExpert Opinion on Drug Safety|September 4, 2019
Safety profile and clinical course of patients with insomnia administered suvorexant by initial treatment status in a post-marketing surveyHideki Sano, Yuko Asai, Makoto Miyazaki, et al.Expert Opinion on Drug Safety|September 30, 2022
A pharmacovigilance analysis of FDA adverse event reporting system events for romosozumabZepeng Chen, Ming Li, Shuzhen Li, et al.Expert Opinion on Drug Safety|October 8, 2022
How do safety warnings on medicines affect prescribing?Barbara Mintzes, Ellen Reynolds, Priya Bahri, et al.Expert Opinion on Drug Safety|March 3, 2021
Safety of treatment options available for postoperative painZhaosheng Jin, Christopher Lee, Kalissa Zhang, et al.Pageof 281